CIC
Cornercap Investment Counsel Portfolio holdings
AUM
$192M
1-Year Return
17.05%
This Quarter Return
+10%
1 Year Return
+17.05%
3 Year Return
+45.89%
5 Year Return
+105.96%
10 Year Return
+138.93%
AUM
$338M
AUM Growth
-$276M
(-45%)
Cap. Flow
-$323M
Cap. Flow
% of AUM
-95.42%
Top 10 Holdings %
Top 10 Hldgs %
8.28%
Holding
665
New
63
Increased
10
Reduced
440
Closed
152
Top Buys
| 1 |
T Rowe Price
TROW
|
$1.58M |
| 2 |
Northern Trust
NTRS
|
$1.56M |
| 3 |
Avery Dennison
AVY
|
$1.55M |
| 4 |
United Parcel Service
UPS
|
$1.51M |
| 5 |
ConocoPhillips
COP
|
$1.39M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$4.9M |
| 2 |
Apple
AAPL
|
$4.69M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$4.39M |
| 4 |
Microsoft
MSFT
|
$3.57M |
| 5 |
Johnson & Johnson
JNJ
|
$3.57M |
Sector Composition
| 1 | Financials | 20.18% |
| 2 | Technology | 15.55% |
| 3 | Healthcare | 12.24% |
| 4 | Industrials | 11.34% |
| 5 | Consumer Discretionary | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
Rapid7
RPD
$1.31B
| $208K | 0.06% |
5,207
-5,299
| -50% | -$211K |
|
477
Verint Systems
VRNT
$1.23B
| $206K | 0.06% |
8,135
-7,900
| -49% | -$200K |
|
478
Heritage Insurance Holdings
HRTG
$733M
| $206K | 0.06% |
+16,803
| New | +$206K |
|
479
Ziff Davis
ZD
$1.56B
| $204K | 0.06% |
4,201
-3,652
| -47% | -$178K |
|
480
Gray Television
GTN
$626M
| $192K | 0.06% |
35,769
-89,357
| -71% | -$479K |
|
481
Apple Hospitality REIT
APLE
$3.06B
| $184K | 0.05% |
12,400
-17,850
| -59% | -$265K |
|
|
LAND
482
Gladstone Land Corp
LAND
$325M
| $180K | 0.05% |
+12,921
| New | +$180K |
|
483
Cogent Biosciences
COGT
$1.77B
| $175K | 0.05% |
16,165
-17,973
| -53% | -$194K |
|
484
Upwork
UPWK
$2.14B
| $171K | 0.05% |
16,334
-19,940
| -55% | -$208K |
|
485
Annexon
ANNX
$238M
| $134K | 0.04% |
22,604
-23,453
| -51% | -$139K |
|
486
Replimune Group
REPL
$487M
| $133K | 0.04% |
12,167
-14,000
| -54% | -$153K |
|
|
PSTX
487
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $123K | 0.04% |
43,177
-36,046
| -45% | -$103K |
|
488
Foghorn Therapeutics
FHTX
$318M
| $122K | 0.04% |
13,147
-12,420
| -49% | -$116K |
|
489
Oric Pharmaceuticals
ORIC
$1.06B
| $103K | 0.03% |
10,063
-11,675
| -54% | -$120K |
|
490
Monte Rosa Therapeutics
GLUE
$298M
| $102K | 0.03% |
19,236
-22,681
| -54% | -$120K |
|
491
Black Diamond Therapeutics
BDTX
$167M
| $98.2K | 0.03% |
22,583
-25,527
| -53% | -$111K |
|
492
Allogene Therapeutics
ALLO
$251M
| $79.9K | 0.02% |
28,533
-34,937
| -55% | -$97.8K |
|
493
Vir Biotechnology
VIR
$714M
| $79.3K | 0.02% |
10,587
-11,937
| -53% | -$89.4K |
|
494
Relay Therapeutics
RLAY
$697M
| $76.5K | 0.02% |
10,811
-12,043
| -53% | -$85.3K |
|
495
Vanda Pharmaceuticals
VNDA
$271M
| $75.5K | 0.02% |
16,101
-16,460
| -51% | -$77.2K |
|
496
Fate Therapeutics
FATE
$115M
| $72.4K | 0.02% |
20,683
-22,789
| -52% | -$79.8K |
|
497
Generation Bio
GBIO
$39.7M
| $71.6K | 0.02% |
2,900
-2,842
| -49% | -$70.2K |
|
498
Sana Biotechnology
SANA
$741M
| $67.5K | 0.02% |
+16,218
| New | +$67.5K |
|
499
C4 Therapeutics
CCCC
$189M
| $67.2K | 0.02% |
11,791
-15,345
| -57% | -$87.5K |
|
500
Lyell Immunopharma
LYEL
$246M
| $65.9K | 0.02% |
2,388
-2,426
| -50% | -$67K |
|